Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Argus Research Upgrades Biogen to Buy

Argus Research Upgrades Biogen to Buy

Argus Research analyst Jasper Hellweg upgrades Biogen (NASDAQ:BIIB) from Hold to Buy.

byBenzinga Newsdesk

October 7, 2022

1 minute read

Argus Research analyst Jasper Hellweg upgrades Biogen (NASDAQ:BIIB) from Hold to Buy.

JPMorgan Chase CEO Jamie Dimon Issues Stark Warning Amid Israel-Hamas War: ‘The Most Dangerous Time In Decades’

By Benzinga Neuro

October 14, 12:23 AM

Jamie Dimon voiced concern about intensifying global threats, labeling these times as some of the most perilous in recent decades.

JPM

Analyst Ratings

5 Analysts Have This to Say About Progyny

By Benzinga Insights

May 22, 1:02 PM

Progyny (NASDAQ:PGNY) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

PGNY

Jim Cramer Sees Nvidia As Going ‘From Star Of The Show To Being The Goat Of The Game’

By Benzinga Neuro

April 22, 11:17 PM

CNBC's Jim Cramer, on Monday, highlighted the positive performance of the stock market but cautioned that the upcoming Big Tech earnings could determine the market's future.

GOOG

Analyst Ratings

Forecasting The Future: 11 Analyst Projections For Boston Beer Co

By Benzinga Insights

May 14, 9:00 AM

Boston Beer Co (NYSE:SAM) has been analyzed by 11 analysts in the last three months, revealing a diverse…

SAM

Argus Research Upgrades Biogen to Buy

Related Posts

JPMorgan Chase CEO Jamie Dimon Issues Stark Warning Amid Israel-Hamas War: ‘The Most Dangerous Time In Decades’

5 Analysts Have This to Say About Progyny

Jim Cramer Sees Nvidia As Going ‘From Star Of The Show To Being The Goat Of The Game’

Forecasting The Future: 11 Analyst Projections For Boston Beer Co